USE OF GLYCOSIDASES IN THE PRODUCTION OF OLIGOSACCHARIDES
Disclosed is a method for the production of a desired oligosaccharide using a genetically-engineered microbial host cell, and said genetically-engineered microbial host cell which has been genetically engineered to express a heterologous glycosidase which is able to intracellularly degrade metabolic saccharide by-products that are generated during the intracellular biosynthesis of the desired oligosaccharide.
1 . A method for production of a desired oligosaccharide using a genetically-engineered microbial host cell, the method comprising:
(i) providing a genetically-engineered microbial host cell that is able to produce the desired oligosaccharide, wherein the microbial host cell has been genetically engineered to express at least one heterologous glycosidase which is able to intracellularly degrade metabolic saccharide by-products that are generated during the intracellular biosynthesis of the desired oligosaccharide, and wherein the microbial host cell is able to recycle the degradation products resulting from the enzymatic activity of said glycosidase for the production of the desired oligosaccharide;
(ii) cultivating the genetically-engineered microbial host cell under conditions and in a medium permissive for production of the desired oligosaccharide, thereby producing the desired oligosaccharide; and
(iii) optionally, recovering the desired oligosaccharide.
2 . A genetically-engineered microbial host cell for producing a desired oligosaccharide, wherein said microbial host cell is
a) able to produce the desired oligosaccharide;
b) has been genetically engineered to express at least one heterologous glycosidase which is able to intracellularly degrade one or more metabolic saccharide by-products that are generated during the intracellular biosynthesis of the desired oligosaccharide; and
c) is able to recycle one or more degradation products resulting from the enzymatic activity of said glycosidase for production of the desired oligosaccharide.
3 . The method according to claim 1 or a genetically-engineered host cell capable of use therewith, wherein the heterologous glycosidase is selected from the group consisting of fucosidases, sialidases, hexosaminidases, galactosidases and glucosidases.
4 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the heterologous glycosidase is selected from the group consisting of α-1,2-fucosidases, α-1,3-fucosidases, α-2,3-sialidases, α-2,6-sialidases, α-2,8-sialidases, β-1,3-galactosidases, β-1,4-galactosidases, β-1,6-galactosidases, β-N-acetylhexosaminidases and β-1,3-glucosidases.
5 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the genetically-engineered microbial host cell has been genetically engineered to express a heterologous glycosyltransferase, optionally as glycosyltransferase selected from the group consisting of fucosyltransferases, sialyltransferases, galactosyltransferases, N-acetyl-glucosaminyltransferases and glucosyltransferases.
6 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the microbial host cell has been genetically engineered to express a heterologous α-1,3-fucosyltransferase and a heterologous α-1,2-fucosidase.
7 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the microbial host cell has been genetically engineered to express a heterologous α-1,2-fucosyltransferase and a heterologous α-1,3-fucosidase.
8 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the microbial host cell has been genetically engineered to express a heterologous β-1,3-N-acetylglucosaminyltransferase, a heterologous α-1,2-fucosyltransferase, a heterologous β-1,3-galactosyltransferase and a heterologous α-1,3-fucosidase.
9 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the microbial host cell has been genetically engineered to express a heterologous α-2,6-sialyltransferase and a heterologous α-2,3-sialidase.
10 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the microbial host cell has been genetically engineered to express a heterologous β-1,3-N-acetylglucosaminyltransferase, a heterologous β-1,4-galactosyltransferase and a heterologous β-1,3-galactosidase and/or β-1,3-glucosidase and/or galactan-β-1,3-galactosidase.
11 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the microbial host cell has been genetically engineered to express a heterologous β-1,3-N-acetylglucosaminyltransferase, a heterologous β-1,3-galactosyltransferase and a heterologous β-1,3-glucosidase and/or a galactan-β-1,3-galactosidase.
12 . The method of claim 1 or a genetically-engineered microbial host cell useful therewith, wherein the desired oligosaccharide is a human milk oligosaccharide, optionally a human milk oligosaccharide selected from the group consisting of 2′-fucosyllactose (2′-FL), 3-fucosyllactose (3-FL), 2′,3-difucosyllactose, lacto-N-triose II, lacto-N-tetraose, lacto-N-neotetraose, lacto-N-fucopentaose I, lacto-N-neofucopentaose I, lacto-N-fucopentaose II, lacto-N-fucopentaose III, lacto-N-fucopentaose V, lacto-N-neofucopentaose V, lacto-N-difucohexaose I, lacto-N-difucosylhexaose II, para-Lacto-N-fucosylhexaose, fucosyl-lacto-N-sialylpentaose b, fucosyl-lacto-N-sialylpentaose c, fucosyl-lacto-N-sialylpentaose c, disialyl-lacto-N-fucopentaose, 3-fucosyl-3′-sialyllactose, 3-fucosyl-6′-sialyllactose, lacto-N-neodifucohexaose I, 3′-sialyllactose, 6′-sialyllactose, sialyllacto-N-tetraose a (LST-a), sialyllacto-N-tetraose b (LST-b), sialyllacto-N-tetraose c (LST-c), and disialyllacto-N-tetraose.
13 . A product comprising the genetically-engineered microbial host cell according to claim 2 for production of a desired oligosaccharide, optionally an oligosaccharide selected from the group consisting of HMOs.
14 . An oligosaccharide, optionally an oligosaccharide selected from the group consisting of HMOs, produced by the method according to claim 1 or a genetically engineered microbial host cell useful therewith, for manufacture of a nutritional composition.
15 . A nutritional composition comprising at least one oligosaccharide that has been produced by the method of claim 1 or by use of a genetically-engineered microbial host cell useful therewith, wherein the at least one oligosaccharide is optionally a HMO.